DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Syed-Abdul MM, Parks EJ, Gaballah AH. et al.
Fatty acid synthase inhibitor TVB-2640 reduces hepatic de novo lipogenesis in males with metabolic abnormalities.
Hepatology 2020;
72 (01) 103-118
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.